+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2, Glucose), By Disease, By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • October 2023
  • Region: Global
  • Grand View Research
  • ID: 5899606
Description Jump to:
The global comprehensive metabolic panel testing market size is expected to reach USD 20.87 billion by 2030. The market is expected to expand at a CAGR of 9.1% from 2023 to 2030. The market driven by an increasing global disease burden and the emergence of novel diagnostic products.

Rising prevalence of chronic diseases coupled with increasing need to curb healthcare expenditure are expected to boost the CMP testing market by increasing the demand for early disease diagnosis and regular monitoring. Introduction of technologically advanced products, such as biochips, microarrays, and companion diagnostics, has driven the necessity for early detection of anomalies. CMP testing offers a cost-effective and time-saving method for evaluating 14 analytes for identification, diagnosis, or monitoring of several diseases.

Rising consumer awareness regarding healthcare is one of the major factors anticipated to drive the market for CMP testing. Many organizations worldwide are working toward increasing awareness pertaining to diseases, available treatment options, and benefits of early diagnosis and precautions. For instance, the International Diabetes Foundation and the American Diabetes Association are some of the key organizations that emphasize the urgent need for diagnosing and monitoring diabetes through several awareness campaigns and other modes of advertisement.

The buying behavior of consumers is moderately complex in the comprehensive metabolic panel testing market, due to subtle differences in product prices. The products offered by various market players have been strategically priced to increase competitive rivalry. As the market becomes increasingly competitive, consumer needs are anticipated to reach at an all-time high for improved diagnostics - in terms of safety, efficacy, sensitivity, and specificity.

The medical diagnostics landscape has undergone a paradigm shift over the last few years, driven by the launch of improved diagnostic products and introduction of biomarkers. However, recurrence and disease progression remain high, especially among geriatric patients. Strong unmet needs present a key opportunity to develop breakthrough first-in-class diagnostics in the CMP testing space.

Comprehensive Metabolic Panel Testing Market Report Highlights

  • The kidney diseases segment accounted for the largest revenue share of 32.71% in 2022, and the segment is driven by a high disease prevalence and maximum utilization of analytes.
  • The diabetes segment is expected to grow at the fastest CAGR of 9.9% during the forecast period. Nearly 50% of diabetics remain undiagnosed, presenting a lucrative opportunity for growth for the comprehensive metabolic panel testing market.
  • The PoC segment is expected to grow at the fastest CAGR of 9.8% over the forecast period. The PoC CMP tests are driven by their ease of operation, portability, speed of results, and lesser requirement of the sample.
  • The laboratories segment accounted for the highest revenue share of 59.97% in 2022, driven by easy availability, high market penetration, increased usage, and clinically significant results.
  • Asia Pacific is expected to grow at the highest CAGR of 11.7% over the forecast period, driven by improvements in healthcare infrastructure, a rise in the number of older people, who are more susceptible to chronic illnesses, growth in consumer awareness, a rise in disposable income, and overall economic development.


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Analytes
1.1.2. Disease
1.1.3. End use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Analytes outlook
2.2.2. Disease outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Comprehensive Metabolic Panel Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Comprehensive Metabolic Panel Testing Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Comprehensive Metabolic Panel Testing Market: Analytes Estimates & Trend Analysis
4.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
4.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
4.3. K+
4.3.1. K+ market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Na+
4.4.1. Na+ market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Cl-
4.5.1. Cl- market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. CO2
4.6.1. CO2 market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Glucose
4.7.1. Glucose market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. BUN
4.8.1. BUN market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Creatinine
4.9.1. Creatinine market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Ca++
4.10.1. Ca++ market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Albumin
4.11.1. Albumin market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Total Protein
4.12.1. Total protein market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. ALP
4.13.1. ALP market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. ALT
4.14.1. ALT market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. AST
4.15.1. AST market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Total Bilirubin
4.16.1. Total bilirubin market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Comprehensive Metabolic Panel Testing Market: Disease Estimates & Trend Analysis
5.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
5.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Kidney Diseases
5.3.1. Kidney diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Liver Diseases
5.4.1. Liver diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Diabetes
5.5.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Comprehensive Metabolic Panel Testing Market: End-Use Estimates & Trend Analysis
6.1. Comprehensive Metabolic Panel Testing Market: Key Takeaways
6.2. Comprehensive Metabolic Panel Testing Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Laboratories
6.3.1. Laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.2. Emergency departments
6.3.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.3. Hospital wards
6.3.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.4. Primary care
6.3.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.5. Pharmacy
6.3.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
6.3.6. Telemedicine
6.3.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. PoC
6.4.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.2. Emergency departments
6.4.2.1. Emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.3. Hospital wards
6.4.3.1. Hospital wards market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.4. Primary care
6.4.4.1. Primary care market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.5. Pharmacy
6.4.5.1. Pharmacy market estimates and forecasts, 2018 to 2030 (USD Million)
6.4.6. Telemedicine
6.4.6.1. Telemedicine market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. PoC (Instruments)
6.5.1. PoC market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.2. Piccolo Xpress
6.5.2.1. Piccolo xpress market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.3. Skyla-HB1
6.5.3.1. Skyla-HB1 market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.4. DRI-CHEM NX500
6.5.4.1. DRI-CHEM NX500 market estimates and forecasts, 2018 to 2030 (USD Million)
6.5.5. Others
6.5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Comprehensive Metabolic Panel Testing Market by Region: Key Marketplace Takeaway
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. Abbott
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Quest Diagnostics
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Laboratory Corporation of America Holdings
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. Sonic Healthcare Limited
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Unipath
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. SYNLAB International GmbH
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. ARUP Laboratories
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Genoptix Inc.
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Nova Biomedical
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 3 North America comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 4 North America comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 5 North America comprehensive metabolic panel testing market, by region, 2018-2030 (USD Million)
Table 6 U.S. comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 7 U.S. comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 8 U.S. comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 9 Canada comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 10 Canada comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 11 Canada comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 12 Europe comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 13 Europe comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 14 Europe comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 15 Europe comprehensive metabolic panel testing market, by region, 2018-2030 (USD Million)
Table 16 Germany comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 17 Germany comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 18 Germany comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 19 UK comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 20 UK comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 21 UK comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 22 France comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 23 France comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 24 France comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 25 Italy comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 26 Italy comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 27 Italy comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 28 Spain comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 29 Spain comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 30 Spain comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 31 Denmark comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 32 Denmark comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 33 Denmark comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 34 Sweden comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 35 Sweden comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 36 Sweden comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 37 Norway comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 38 Norway comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 39 Norway comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 40 Asia Pacific comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 41 Asia Pacific comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 42 Asia Pacific comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 43 Asia Pacific comprehensive metabolic panel testing market, by region, 2018-2030 (USD Million)
Table 44 Japan comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 45 Japan comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 46 Japan comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 47 China comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 48 China comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 49 China comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 50 India comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 51 India comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 52 India comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 53 Australia comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 54 Australia comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 55 Australia comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 56 Thailand comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 57 Thailand comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 58 Thailand comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 59 South Korea comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 60 South Korea comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 61 South Korea comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 62 Latin America comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 63 Latin America comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 64 Latin America comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 65 Latin America comprehensive metabolic panel testing market, by region, 2018-2030 (USD Million)
Table 66 Brazil comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 67 Brazil comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 68 Brazil comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 69 Mexico comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 70 Mexico comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 71 Mexico comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 72 Argentina comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 73 Argentina comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 74 Argentina comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 75 Middle East and Africa comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 76 Middle East and Africa comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 77 Middle East and Africa comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 78 Middle East and Africa comprehensive metabolic panel testing market, by region, 2018-2030 (USD Million)
Table 79 South Africa comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 80 South Africa comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 81 South Africa comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 82 Saudi Arabia comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 83 Saudi Arabia comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 84 Saudi Arabia comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 85 UAE comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 86 UAE comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 87 UAE comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
Table 88 Kuwait comprehensive metabolic panel testing market, by analytes, 2018-2030 (USD Million)
Table 89 Kuwait comprehensive metabolic panel testing market, by disease, 2018-2030 (USD Million)
Table 90 Kuwait comprehensive metabolic panel testing market, by end use, 2018-2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 7 Comprehensive metabolic panel testing: Market outlook
Fig. 8 Comprehensive metabolic panel testing: Competitive insights
Fig. 9 Parent market outlook
Fig. 10 Related/ancillary market outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Comprehensive metabolic panel testing market driver impact
Fig. 13 Comprehensive metabolic panel testing market restraint impact
Fig. 14 Comprehensive metabolic panel testing market strategic initiatives analysis
Fig. 15 Comprehensive metabolic panel testing market: Disease movement analysis
Fig. 16 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
Fig. 17 Kidney diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 18 Liver diseases market estimates and forecasts, 2018-2030 (USD Million)
Fig. 19 Diabetes market estimates and forecasts, 2018-2030 (USD Million)
Fig. 20 Others market estimates and forecasts, 2018-2030 (USD Million)
Fig. 21 Comprehensive metabolic panel testing market: Disease movement analysis
Fig. 22 Comprehensive metabolic panel testing market: Disease outlook and key takeaways
Fig. 23 K+ market estimates and forecasts, 2018-2030 (USD Million)
Fig. 24 Na+ market estimates and forecasts, 2018-2030 (USD Million)
Fig. 25 Cl- market estimates and forecasts, 2018-2030 (USD Million)
Fig. 26 CO2 market estimates and forecasts, 2018-2030 (USD Million)
Fig. 27 Glucose market estimates and forecasts, 2018-2030 (USD Million)
Fig. 28 BUN market estimates and forecasts, 2018-2030 (USD Million)
Fig. 29 Creatinine market estimates and forecasts, 2018-2030 (USD Million)
Fig. 30 Ca++ market estimates and forecasts, 2018-2030 (USD Million)
Fig. 31 Albumin market estimates and forecasts, 2018-2030 (USD Million)
Fig. 32 Total protein market estimates and forecasts, 2018-2030 (USD Million)
Fig. 33 ALP market estimates and forecasts, 2018-2030 (USD Million)
Fig. 34 ALT market estimates and forecasts, 2018-2030 (USD Million)
Fig. 35 AST market estimates and forecasts, 2018-2030 (USD Million)
Fig. 36 Total bilirubin market estimates and forecasts, 2018-2030 (USD Million)
Fig. 37 Comprehensive metabolic panel testing market: End-Use movement analysis
Fig. 38 Comprehensive metabolic panel testing market: End-Use outlook and key takeaways
Fig. 39 Laboratories market estimates and forecasts, 2018-2030 (USD Million)
Fig. 40 PoC market estimates and forecasts, 2018-2030 (USD Million)
Fig. 41 PoC (instruments) market estimates and forecasts, 2018-2030 (USD Million)
Fig. 42 Global comprehensive metabolic panel testing market: Regional movement analysis
Fig. 43 Global comprehensive metabolic panel testing market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 45 U.S. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 46 Canada market estimates and forecasts, 2018-2030 (USD Million)
Fig. 47 Europe market estimates and forecasts, 2018-2030 (USD Million)
Fig. 48 UK market estimates and forecasts, 2018-2030 (USD Million)
Fig. 49 Germany market estimates and forecasts, 2018-2030 (USD Million)
Fig. 50 France market estimates and forecasts, 2018-2030 (USD Million)
Fig. 51 Italy market estimates and forecasts, 2018-2030 (USD Million)
Fig. 52 Spain market estimates and forecasts, 2018-2030 (USD Million)
Fig. 53 Denmark market estimates and forecasts, 2018-2030 (USD Million)
Fig. 54 Sweden market estimates and forecasts, 2018-2030 (USD Million)
Fig. 55 Norway market estimates and forecasts, 2018-2030 (USD Million)
Fig. 56 Asia Pacific market estimates and forecasts, 2018-2030 (USD Million)
Fig. 57 Japan market estimates and forecasts, 2018-2030 (USD Million)
Fig. 58 China market estimates and forecasts, 2018-2030 (USD Million)
Fig. 59 India market estimates and forecasts, 2018-2030 (USD Million)
Fig. 60 Australia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 61 Thailand market estimates and forecasts, 2018-2030 (USD Million)
Fig. 62 South Korea market estimates and forecasts, 2018-2030 (USD Million)
Fig. 63 Latin America market estimates and forecasts, 2018-2030 (USD Million)
Fig. 64 Brazil market estimates and forecasts, 2018-2030 (USD Million)
Fig. 65 Mexico market estimates and forecasts, 2018-2030 (USD Million)
Fig. 66 Argentina market estimates and forecasts, 2018-2030 (USD Million)
Fig. 67 Middle East and Africa. market estimates and forecasts, 2018-2030 (USD Million)
Fig. 68 South Africa market estimates and forecasts, 2018-2030 (USD Million)
Fig. 69 Saudi Arabia market estimates and forecasts, 2018-2030 (USD Million)
Fig. 70 UAE market estimates and forecasts, 2018-2030 (USD Million)
Fig. 71 Kuwait market estimates and forecasts, 2018-2030 (USD Million)

Companies Mentioned

  • Abbott
  • Quest Diagnostics
  • Laboratory Corporation of America Holdings
  • Sonic Healthcare Limited
  • Unipath
  • SYNLAB International GmbH
  • ARUP Laboratories
  • Genoptix Inc.
  • Nova Biomedical

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedOctober 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 10.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.87 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Global Comprehensive Metabolic Panel Testing Market by Disease (Diabetes, Kidney Disease, Liver Disease), Test Type (Electrolytes, Glucose, Kidney Tests), End-User - Forecast 2024-2030 - Product Image

Global Comprehensive Metabolic Panel Testing Market by Disease (Diabetes, Kidney Disease, Liver Disease), Test Type (Electrolytes, Glucose, Kidney Tests), End-User - Forecast 2024-2030

  • Report
  • 195 Pages
  • Global
From
Global Thyroid Function Testing Market Size, Share & Trends Analysis Report by Test Type (TSH Test, T4 Test, T3 Test, Free T4 Test), End-use (Clinics, Diagnostic Laboratories, Hospitals, Research Laboratories & Institutes), Region, and Segment Forecasts, 2024-2030 - Product Image

Global Thyroid Function Testing Market Size, Share & Trends Analysis Report by Test Type (TSH Test, T4 Test, T3 Test, Free T4 Test), End-use (Clinics, Diagnostic Laboratories, Hospitals, Research Laboratories & Institutes), Region, and Segment Forecasts, 2024-2030

  • Report
  • 125 Pages
  • Global
From
Global Metabolic Testing Solutions Market by Product, Technology, Application, End-Use - Forecast 2024-2030 - Product Image

Global Metabolic Testing Solutions Market by Product, Technology, Application, End-Use - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024 - Product Image

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.